AMGN vs SYK
By Alex · Tickerpine
Amgen Inc. vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | SYK |
|---|---|---|
| Price | $416.18 | $347.21 |
| Market cap | $225.15B | $133.18B |
| P/E ratio | 25.7 | 36.1 |
| ROE | 91.47% | 16.51% |
| Profit margin | 22.95% | 14.43% |
| Revenue growth | 9.50% | 9.40% |
| Dividend yield | 2.43% | 1.01% |
| Beta | 0.41 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs SYK in plain English
- AMGN is the bigger company — about 1.7× the market cap of SYK.
- AMGN is cheaper on earnings (P/E 25.7 vs 36.1).
- AMGN earns a higher return on equity (91% vs 17%).
- AMGN is growing revenue faster (10% vs 9%).
- AMGN has the higher dividend yield (2.43% vs 1.01%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.